ConductScience.org, home

Gene · 80331

DNAJC5: DnaJ heat shock protein family (Hsp40) member C5

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. DNAJC5: DnaJ heat shock protein family (Hsp40) member C5. Genes, record 80331. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/80331

On this page

Gene

Symbol
DNAJC5
HGNC
Name
DnaJ heat shock protein family (Hsp40) member C5
HGNC
NCBI Gene ID
80331
NCBI Gene
HGNC ID
HGNC:16235
HGNC
Ensembl
ENSG00000101152
NCBI Gene
Aliases
CLN4, CLN4B, CSP, DNAJC5A, FLJ00118, FLJ13070, mir-941-2, mir-941-3, mir-941-4, mir-941-5
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9H3Z4DnaJ homolog subfamily C member 51982Ensembl, GeneID, HGNC

Source UniProt

Patents33

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21266Q9H3Z4Espacenet
JP 2026004568 A2026-01-1444132Q9H3Z4Espacenet
EP 4650780 A22025-11-197833Q9H3Z4Espacenet
JP 2025529142 A2025-09-041294Q9H3Z4Espacenet
US 12371689 B22025-07-291294Q9H3Z4Espacenet
JP 2025517970 A2025-06-127833Q9H3Z4Espacenet
JP 2024112982 A2024-08-214343Q9H3Z4Espacenet
JP 2023521663 A2023-05-25265Q9H3Z4Espacenet
JP 2022184996 A2022-12-134343Q9H3Z4Espacenet
US 11446398 B22022-09-2025337Q9H3Z4Espacenet

1 to 10 of 33

See all 33 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,608

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleDNAJC5 papersNewest fiscal year
ZIAAI001135Pre-erythrocytic malaria vaccines: Discovery and Clinical Development132025
ZIAAI001155Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies122025
D43TW001505Population Biology of African Malaria Vectors and Parasites112025
ZIAAI001020Host Immune Responses to Antigens of Malaria Parasites112025
U19AI089674Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal102025
U19AI129326Malaria Epidemiology and Vector Biology of Anopheles stephensi across Rural and Urban Landscapes in Ethiopia92025
T32AI007417The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program82025
ZIAAI001009Vaccines to Interrupt Malaria Transmission: Clinical Development82025
ZIAAI001007Vaccines to Interrupt Malaria Transmission: Discovery and Assays72025
ZIAAI005107Development of Pre-Erythrocytic Malaria Vaccines and antibodies72025

1 to 10 of 1,608Source NIH's project files

See all 1,608 nih grants

Papers3,340

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Efficacy and Response of R21/Matrix-M in Malaria Vaccine: A Systematic Review and Meta-Analysis of Clinical Trials.Vaccines (Basel)202642797644PubTator, text miningPubMed
Renaming the 'OS-D/CSP' Family (Part 2): '4-Cysteine Soluble Proteins' (4CSPs)-Intracellular Functions.Insects202642783307PubTator, text miningPubMed
Adaptive replacement of low-value proteins in surimi gels as exemplified by cold-plasma-precipitated sarcoplasmic proteins: Cross-linking or filling effect?Food Chem202642753540PubTator, text miningPubMed
Parasite strain turnover and mosquito infectivity in untreated subpatent malaria.J Infect Dis202642742272PubTator, text miningPubMed
Structural modification of raisin pectin fractions by electron beam irradiation.Carbohydr Polym202642692631PubTator, text miningPubMed
Anti-malaria antibody engineering broadens recognition motifs and reveals new homotypic interactions that enhance protective breadth.Nat Commun202642660882PubTator, text miningPubMed
Monoclonal antibody CIS43LS sets the bar for long-acting malaria protection.J Clin Invest202642606125PubTator, text miningPubMed
Chemovaccination with a late-liver-stage antimalarial induces durable immunity against malaria.Science202642594189PubTator, text miningPubMed
Quantitative and Clinical Pharmacology Perspectives on Next-Generation Malaria Prevention Using Vaccines and Long-Acting Monoclonal Antibodies.Clin Transl Sci202642587382PubTator, text miningPubMed
Overcoming immunogenic gaps in malaria subunit vaccines by broadening CSP regions targeted.J Exp Med202642565808PubTator, text miningPubMed

1 to 10 of 3,340

See all 3,340 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/80331

GET https://conductscience.org/api/genes/v1/80331/patents?page=2